CSIMarket Company Name, Ticker, Customers, else..
 
Biolase Inc   (BIOL)
 

Biolase Inc's Suppliers Performance

BIOL's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
BIOL Costs vs Sales of Suppliers Growth Biolase Inc's cost of sales deteriorated by -14.29 % year on year, relative to one quarter ago cost of sales fell by 0 % in Q3.

• More on BIOL Suppliers



Biolase Inc's cost of sales deteriorated by -14.29 % year on year, compare to one quarter ago cost of sales fell by 0 % in Q3.

• More on BIOL Suppliers




Biolase Inc's Comment on Supply Chain


The company sources components and subassemblies primarily from suppliers in the United States, relying mainly on purchase orders rather than formal supply contracts. Three critical components for the Waterlase system—power suppliers, laser crystals, and fiber components—are each obtained from separate single-source suppliers. Although there have been no recent significant delays from these suppliers, any unexpected disruption could substantially affect manufacturing and sales. The company is actively working to identify and qualify alternative suppliers for these key components but cannot guarantee successful qualification or favorable terms. Additionally, the company is subject to inspections by the FDA and other regulatory bodies that may impact manufacturing and related processes.

Biolase Inc's Comment on Supply Chain


The company sources components and subassemblies primarily from suppliers in the United States, relying mainly on purchase orders rather than formal supply contracts. Three critical components for the Waterlase system—power suppliers, laser crystals, and fiber components—are each obtained from separate single-source suppliers. Although there have been no recent significant delays from these suppliers, any unexpected disruption could substantially affect manufacturing and sales. The company is actively working to identify and qualify alternative suppliers for these key components but cannot guarantee successful qualification or favorable terms. Additionally, the company is subject to inspections by the FDA and other regulatory bodies that may impact manufacturing and related processes.







BIOL's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Biolase Inc 0.63 43.72 -32.95 250
SUBTOTAL 0.00 0.00 0.00 -


Sources: Biolase Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Biolase Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.